Medicinal Products

Deferasiroks Pliva 125 mg tablete za oralnu suspenziju

Name Deferasiroks Pliva 125 mg tablete za oralnu suspenziju
Marketing Authorisation Number HR-H-522308269
Active Substance deferasiroks
Composition svaka tableta za oralnu suspenziju sadrži 125 mg deferasiroksa
Pharmaceutical Form tableta za oralnu suspenziju
Packaging [MA Number for Packaging] 28 tableta u blisteru, u kutiji  [HR-H-522308269-01]
28 tableta u blisteru s jediničnom dozom, u kutiji  [HR-H-522308269-02]
30 tableta u blisteru, u kutiji  [HR-H-522308269-03]
30 tableta u blisteru s jediničnom dozom, u kutiji  [HR-H-522308269-04]
84 tablete u blisteru, u kutiji  [HR-H-522308269-05]
84 tableta u blisteru s jediničnom dozom, u kutiji  [HR-H-522308269-06]
98 tableta u blisteru, u kutiji  [HR-H-522308269-07]
98 tableta u blisteru s jediničnom dozom, u kutiji  [HR-H-522308269-08]
Manufacturer Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka
Pliva Hrvatska d.o.o., Zagreb, Hrvatska
Marketing Authorisation Holder Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska
Marketing Authorisation Date 07.04.2022
MA Period of Validity unlimited
Classification Number UP/I-530-09/21-02/195
Registration Number 381-12-01/154-22-03
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code V03AC03
Medicinal product marketed in the Croatia Ne
SmPC download
PL download
Public Assessment Report download
Educational materials
for healthcare professionals
Vodič za zdravstvene radnike, verzija 2
Educational materials
for patients / caregivers
Vodič za bolesnike, verzija 2
Back